Literature DB >> 18566402

Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis.

Anna P Lillis1, Mallary C Greenlee, Irina Mikhailenko, Salvatore V Pizzo, Andrea J Tenner, Dudley K Strickland, Suzanne S Bohlson.   

Abstract

C1q and members of the defense collagen family are pattern recognition molecules that bind to pathogens and apoptotic cells and trigger a rapid enhancement of phagocytic activity. Candidate phagocytic cell receptors responsible for the enhancement of phagocytosis by defense collagens have been proposed but not yet discerned. Engagement of phagocyte surface-associated calreticulin in complex with the large endocytic receptor, low-density lipoprotein receptor-related protein 1 (LRP/CD91), by defense collagens has been suggested as one mechanism governing enhanced ingestion of C1q-coated apoptotic cells. To investigate this possibility, macrophages were derived from transgenic mice genetically deficient in LRP resulting from tissue-specific loxP/Cre recombination. LRP-deficient macrophages were impaired in their ability to ingest beads coated with an LRP ligand when compared with LRP-expressing macrophages, confirming for the first time that LRP participates in phagocytosis. When LRP-deficient and -expressing macrophages were plated on C1q-coated slides, they demonstrated equivalently enhanced phagocytosis of sheep RBC suboptimally opsonized with IgG or complement, compared with cells plated on control protein. In addition, LRP-deficient and -expressing macrophages ingested equivalent numbers of apoptotic Jurkat cells in the presence and absence of serum. Both LRP-deficient and -expressing macrophages ingested fewer apoptotic cells when incubated in the presence of C1q-deficient serum compared with normal mouse serum, and the addition of purified C1q reconstituted uptake to control serum levels. These studies demonstrate a direct contribution of LRP to phagocytosis and indicate that LRP is not required for the C1q-triggered enhancement of phagocytosis, suggesting that other, still undefined, receptor(s) exist to mediate this important innate immune function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18566402      PMCID: PMC2663906          DOI: 10.4049/jimmunol.181.1.364

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus.

Authors:  Y Heidari; A E Bygrave; R J Rigby; K L Rose; M J Walport; H T Cook; T J Vyse; M Botto
Journal:  Genes Immun       Date:  2006-08-31       Impact factor: 2.676

2.  IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo.

Authors:  Carol Anne Ogden; Robert Kowalewski; Yufeng Peng; Vivianne Montenegro; Keith B Elkon
Journal:  Autoimmunity       Date:  2005-06       Impact factor: 2.815

Review 3.  Phagocytosis: elegant complexity.

Authors:  Lynda M Stuart; R Alan B Ezekowitz
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

4.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

5.  Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.

Authors:  L Hu; L S M Boesten; P May; J Herz; N Bovenschen; M V Huisman; J F P Berbée; L M Havekes; B J M van Vlijmen; J T Tamsma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-12       Impact factor: 8.311

Review 6.  Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions.

Authors:  Suzanne S Bohlson; Deborah A Fraser; Andrea J Tenner
Journal:  Mol Immunol       Date:  2006-08-14       Impact factor: 4.407

7.  Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.

Authors:  Shyra J Gardai; Kathleen A McPhillips; S Courtney Frasch; William J Janssen; Anna Starefeldt; Joanne E Murphy-Ullrich; Donna L Bratton; Per-Arne Oldenborg; Marek Michalak; Peter M Henson
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

8.  C1q and MBL, components of the innate immune system, influence monocyte cytokine expression.

Authors:  Deborah A Fraser; Suzanne S Bohlson; Nijole Jasinskiene; Nenoo Rawal; Gail Palmarini; Sol Ruiz; Rosemary Rochford; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2006-04-14       Impact factor: 4.962

9.  Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype.

Authors:  Lynda M Stuart; Kazue Takahashi; Lei Shi; John Savill; R Alan B Ezekowitz
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

10.  C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells.

Authors:  C A Ogden; A deCathelineau; P R Hoffmann; D Bratton; B Ghebrehiwet; V A Fadok; P M Henson
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  32 in total

Review 1.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

2.  Detection and characterization of soluble CD93 released during inflammation.

Authors:  Mallary C Greenlee; Sarah A Sullivan; Suzanne Slater Bohlson
Journal:  Inflamm Res       Date:  2009-07-15       Impact factor: 4.575

3.  Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Authors:  Yifang Chen; Sahil Khanna; Carl S Goodyear; Yong Beom Park; Eyal Raz; Steffen Thiel; Caroline Grönwall; Jaya Vas; David L Boyle; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

Review 4.  Immunogenic cell death in cancer and infectious disease.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Rev Immunol       Date:  2016-10-17       Impact factor: 53.106

5.  Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.

Authors:  Manuel D Galvan; Deborah B Foreman; Erliang Zeng; John C Tan; Suzanne S Bohlson
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

6.  Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin alphaMbeta2: identification of binding sites within alphaMbeta2 for LRP1.

Authors:  Sripriya Ranganathan; Chunzhang Cao; Jason Catania; Molly Migliorini; Li Zhang; Dudley K Strickland
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

7.  Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis.

Authors:  Marc C Pulanco; Jason Cosman; Minh-Minh Ho; Jessica Huynh; Karina Fing; Jacqueline Turcu; Deborah A Fraser
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

8.  The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain.

Authors:  Chen Zhang; Jie An; Dudley K Strickland; Manuel Yepes
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

Review 9.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

10.  Identification of tubby and tubby-like protein 1 as eat-me signals by phage display.

Authors:  Nora B Caberoy; Dony Maiguel; Youngbae Kim; Wei Li
Journal:  Exp Cell Res       Date:  2009-10-22       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.